170 related articles for article (PubMed ID: 24918924)
1. Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis.
Menghini R; Campia U; Tesauro M; Marino A; Rovella V; Rodia G; Schinzari F; Tolusso B; di Daniele N; Federici M; Zoli A; Ferraccioli G; Cardillo C
PLoS One; 2014; 9(6):e99053. PubMed ID: 24918924
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
3. IL-29 Enhances LPS/TLR4-Mediated Inflammation in Rheumatoid Arthritis.
Xu D; Yan S; Wang H; Gu B; Sun K; Yang X; Sun B; Wang X
Cell Physiol Biochem; 2015; 37(1):27-34. PubMed ID: 26278073
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.
Shimamoto A; Chong AJ; Yada M; Shomura S; Takayama H; Fleisig AJ; Agnew ML; Hampton CR; Rothnie CL; Spring DJ; Pohlman TH; Shimpo H; Verrier ED
Circulation; 2006 Jul; 114(1 Suppl):I270-4. PubMed ID: 16820585
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells.
Li X; Tupper JC; Bannerman DD; Winn RK; Rhodes CJ; Harlan JM
Infect Immun; 2003 Aug; 71(8):4414-20. PubMed ID: 12874320
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
Luo X; Xiao B; Xiao Z
DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility.
Ehrentraut S; Frede S; Stapel H; Mengden T; Grohé C; Fandrey J; Meyer R; Baumgarten G
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2170-6. PubMed ID: 17656666
[TBL] [Abstract][Full Text] [Related]
8. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
Mcdonald KA; Huang H; Tohme S; Loughran P; Ferrero K; Billiar T; Tsung A
Mol Med; 2015 Mar; 20(1):639-48. PubMed ID: 25375408
[TBL] [Abstract][Full Text] [Related]
10. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
11. In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia.
Ehrentraut S; Lohner R; Schwederski M; Ehrentraut H; Boehm O; Noga S; Langhoff P; Baumgarten G; Meyer R; Knuefermann P
Shock; 2011 Dec; 36(6):613-20. PubMed ID: 22089127
[TBL] [Abstract][Full Text] [Related]
12. Daphnes Cortex and its licorice-processed products suppress inflammation via the TLR4/NF-κB/NLRP3 signaling pathway and regulation of the metabolic profile in the treatment of rheumatoid arthritis.
Meng X; Zhang X; Su X; Liu X; Ren K; Ning C; Zhang Q; Zhang S
J Ethnopharmacol; 2022 Jan; 283():114657. PubMed ID: 34600080
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.
Leng B; Tang F; Lu M; Zhang Z; Wang H; Zhang Y
Life Sci; 2018 Sep; 209():111-121. PubMed ID: 30081006
[TBL] [Abstract][Full Text] [Related]
14. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
15. Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide.
Kuo WT; Lee TC; Yu LC
Cancer Res; 2016 Aug; 76(16):4684-95. PubMed ID: 27328732
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
17. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).
Quan J; Liu J; Gao X; Liu J; Yang H; Chen W; Li W; Li Y; Yang W; Wang B
J Diabetes; 2014 Jan; 6(1):33-41. PubMed ID: 23826669
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model.
Wang RP; Yao Q; Xiao YB; Zhu SB; Yang L; Feng JM; Li DZ; Li XL; Wu JJ; Chen J
Stress; 2011 Sep; 14(5):567-75. PubMed ID: 21675862
[TBL] [Abstract][Full Text] [Related]
19. The Toll-like receptor 4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function.
Long H; O'Connor BP; Zemans RL; Zhou X; Yang IV; Schwartz DA
PLoS One; 2014; 9(4):e93550. PubMed ID: 24695807
[TBL] [Abstract][Full Text] [Related]
20. Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.
Villacorta L; Chang L; Salvatore SR; Ichikawa T; Zhang J; Petrovic-Djergovic D; Jia L; Carlsen H; Schopfer FJ; Freeman BA; Chen YE
Cardiovasc Res; 2013 Apr; 98(1):116-24. PubMed ID: 23334216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
